AN INTERVENTION TO EVALUATE THE EFFICACY OF AMALAKI RASAYANA IN THE MANAGEMENT OF MENOPAUSAL SYNDROME OF PARTICIPANTS

AN OPEN LABEL SINGLE ARM CLINICAL STUDY TO EVALUATE THE EFFICACY OF AMALAKI RASAYANA IN THE MANAGEMENT OF MENOPAUSAL SYNDROME - NIL

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2026/03/106999

Enrollment

100

Registered

2026-03-27

Start date

Unknown

Completion date

Unknown

Last updated

2026-04-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N951- Menopausal and female climactericstates

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: AMENORRHEA MORE OR OF TWELVE MONTHS SERUM ESTRADIOL LEVEL LESS THAN TWENTY pg PER ml PATIENTS WITH SIGNS AND SYMPTOMS OF MENOPAUSE WITH SIGNED INFORMED CONSENT

Exclusion criteria

Exclusion criteria: PATIENT NOT WILLING TO PARTICIPATE IN CLINICAL TRIAL PATIENTS WITH DOCUMENTED HISTORY OF MALIGNANCY DIABETES HTN OR ANY OTHER MAJOR SYMPTOMATIC ILLNESS PATIENTS ON PROLONGED MEDICATIONS ON CORTICOSTEROIDS ANTIDEPRESSANT TUBERCULAR DRUGS ETC PATIENT HAVING AGE LESS THAN FORTY YEARS AND MORE THAN FIFTY FIVE YEARS PATIENT WITH ANY HISORY OF ORGANIC PELVIC LESION LIKE FIBROID UTERUS PELVIC INFLAMMATORY DISEASE

Design outcomes

Primary

Measure	Time frame
WILL ASSESS IMPROVEMENT IN SYMPTOMS OF MENOPAUSAL SYNDROME AFTER INTERVENTION KF AMALAKI RASAYANATimepoint: DAY 1 DAY 15 DAY 30 DAY 45 DAY 60	—

Secondary

Measure	Time frame
CHANGES WILL BE OBSERVE IN SERUM ESTRADIOL LEVEL AND SERUM CALCIUM LEVELTimepoint: DAY 1 DAY 45	—

Countries

India

Contacts

Public ContactDR PRIYANKA

INSTITUTE FOR AYURVEDA STUDIES AND RESEARCH

drjk67@gmail.com9896033056

Outcome results